RNAi-Based Inhibition Specific for Mutant Alleles in Autosomal Dominant Diseases: Sequence-Dependent and -Independent Discrimination of Mutant and Wild-Type Alleles by siRNA

Cleveland DW (1999) From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 24:515–520CrossRefPubMedGoogle Scholar

Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001a) Duplexes of 21 nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498CrossRefPubMedGoogle Scholar

Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T (2001b) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20:6877–6888CrossRefPubMedGoogle Scholar

Gaspar C, Lopes-Cendes I, Hayes S (2001) Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study. Am J Hum Genet 68:523–528CrossRefPubMedGoogle Scholar

Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 30:1757–1766CrossRefPubMedGoogle Scholar

Ikeda H, Yamaguchi M, Satoshi S, Aze Y, Narumiya S, Kakizuka A (1996) Expanded polyglutamine in the Machado-Joseph disease protein induced cell death in vitro and in vivo. Nat Genet 13:196–202CrossRefPubMedGoogle Scholar

Kawaguchi Y, Okamoto T, Taniwaki M (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 8:221–228CrossRefPubMedGoogle Scholar

Kobayashi T, Tanaka K, Inoue K, Kakizuka A (2002) Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells. J Biol Chem 277:47358–47365PubMedGoogle Scholar

Matsumura R, Takayanagi T, Murata K, Futamura N, Hirano M, Ueno S (1996) Relationship of (CAG)nC configuration to repeat instability of the Machado-Joseph disease gene. Hum Genet 98:643–645CrossRefPubMedGoogle Scholar

Radunivic T, Leigh PN (1996) Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis; correlation between genotype and clinical features. J Neurol Neurosurg Psychistry 61:565–572Google Scholar

Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O’Regan JP and Deng H (1993) Mutations in Cu, Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature 362:59–62CrossRefPubMedGoogle Scholar

Ross CA (1995) When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15:493–496CrossRefPubMedGoogle Scholar

Wang G, Sawai N, Kotliarova S, Kanazawa I, Nukina N (2000) Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum Mol Genet 9:1795–1803PubMedGoogle Scholar

Yokota T, Sakamoto N, Enomoto Y, Tanabe Y, Maekawa, Makoto Miyagishi M, Taira K, Watanabe M, Mizusawa H (2003) Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 4:602–608CrossRefPubMedGoogle Scholar

Yoshinari K, Miyagishi M, Taira K (2004) Effect on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res 32:691–699CrossRefPubMedGoogle Scholar